Global Implantable Drug Delivery Devices Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

The implantable drug delivery devices market consists of sales of implantable drug delivery devices and related services by companies that manufacture them. Implantable drug delivery devices are drug delivery systems implanted by surgery to allow site-specific drug administration at the tissue or organ where the drug is most needed.

Global Implantable Drug Delivery Devices Market Size And Drivers:

The global implantable drug delivery devices market is expected to grow from $18.821 billion in 2020 to $20.137 billion in 2021 at a compound annual growth rate (CAGR) of 7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $29.846 billion in 2025 at a CAGR of 10%. The rise in the incidence of target diseases such as diabetic retinopathy, cancer, cardiovascular diseases and other chronic diseases is expected to drive the implantable drug delivery devices market.

Request For A Sample For The Global Implantable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3303&type=smp

Trends In The Global Implantable Drug Delivery Devices Market

Companies and researchers are focusing on developing 3D implantable drug delivery devices. 3D printed titanium transcutaneous ports are implanted behind the patient's ear, allowing healthcare professionals to access the catheters. For instance, in February 2020, Renishaw and Herantis Pharma announced the award-winning device, which received positive results in phase 2 trials, that consists of up to four catheters implanted in the relevant brain areas. Researchers at King Abdullah University of Science and Technology have introduced a miniaturized drug delivery system suitable for in-vivo biomedical applications. The system consists of an electrolytic pump, which operates a micro bellows membrane as an actuator for delivery through microneedles. A two-photon 3D printing technique was used to make a reservoir equipped with a microneedle.

Global Implantable Drug Delivery Devices Market Segments:
The global implantable drug delivery devices market is further segmented –
By Product: Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps, Others
By Technology: Diffusion, Osmotic, Magnetic, Others
By Application: Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others
By Geography: The global implantable drug delivery devices market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Implantable Drug Delivery Devices Market At:

Implantable Drug Delivery Devices Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides implantable drug delivery devices market overviews, analyzes and forecasts market size and growth for the global implantable drug delivery devices market, implantable drug delivery devices market share, implantable drug delivery devices market players, implantable drug delivery devices market segments and geographies, implantable drug delivery devices market’s leading competitors’ revenues, profiles and market shares. The implantable drug delivery devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.